Sebastien Lalanne

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Managing High-Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service.

Managing High-Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service.

Journal: Clinical and translational science

Published: July 15, 2025

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 15, 2025

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 11, 2025

Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study.

Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 23, 2024

Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials.

Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials.

Journal: Clinical pharmacology and therapeutics

Published: May 21, 2024

Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient.

Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient.

Journal: The Journal of antimicrobial chemotherapy

Published: April 01, 2024

A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.

A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.

Journal: Therapie

Published: March 14, 2024

Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study.

Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study.

Journal: International journal of antimicrobial agents

Published: June 08, 2023

Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB).

Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB).

Journal: International journal of antimicrobial agents

Published: February 13, 2023

Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo model.

Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo model.

Journal: The Journal of antimicrobial chemotherapy

Published: December 04, 2022

Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold.

Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold.

Journal: Antibiotics (Basel, Switzerland)

Published: October 12, 2022

Comparison of different equations for renal function evaluation as proxies for antibiotic drug clearance: The examples of amoxicillin and cloxacillin.

Comparison of different equations for renal function evaluation as proxies for antibiotic drug clearance: The examples of amoxicillin and cloxacillin.

Journal: Clinical biochemistry

Published: May 22, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026